Amgen (AMGN) Accumulated Expenses (2016 - 2025)
Historic Accumulated Expenses for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $18.5 billion.
- Amgen's Accumulated Expenses rose 499.97% to $18.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.5 billion, marking a year-over-year increase of 499.97%. This contributed to the annual value of $18.5 billion for FY2025, which is 499.97% up from last year.
- As of Q4 2025, Amgen's Accumulated Expenses stood at $18.5 billion, which was up 499.97% from $16.8 billion recorded in Q3 2025.
- Amgen's 5-year Accumulated Expenses high stood at $18.5 billion for Q4 2025, and its period low was $9.0 billion during Q2 2021.
- In the last 5 years, Amgen's Accumulated Expenses had a median value of $13.7 billion in 2023 and averaged $13.4 billion.
- As far as peak fluctuations go, Amgen's Accumulated Expenses plummeted by 321.05% in 2021, and later soared by 3009.01% in 2023.
- Quarter analysis of 5 years shows Amgen's Accumulated Expenses stood at $10.7 billion in 2021, then rose by 16.71% to $12.5 billion in 2022, then rose by 22.64% to $15.4 billion in 2023, then rose by 14.86% to $17.6 billion in 2024, then increased by 5.0% to $18.5 billion in 2025.
- Its Accumulated Expenses stands at $18.5 billion for Q4 2025, versus $16.8 billion for Q3 2025 and $15.0 billion for Q2 2025.